Blue Light Cystoscopy Significantly Decreases Recurrence Risk in Bladder Cancer Patients
|
By HospiMedica International staff writers Posted on 23 Mar 2023 |
|
Bladder cancer is a significant global health concern, ranking as the 8th most common cancer worldwide and the 5th most common in men. In 2020, there were 1,720,000 prevalent cases (5-year prevalence rate), 573,000 new cases, and over 200,000 deaths attributed to the disease. Men are more likely to be affected, accounting for approximately 75% of all cases. Bladder cancer also has a high recurrence rate, with up to 61% of patients experiencing recurrence within the first year and up to 78% over five years. Furthermore, it has the highest lifetime treatment costs per patient among all cancers, as patients often undergo multiple cystoscopies due to the high risk of recurrence. Improved diagnosis and management strategies for bladder cancer are urgently needed to benefit both patients and healthcare systems. Now, two new studies have highlighted the benefits of the Blue Light Cystoscopy (BLC) procedure in bladder cancer management.
Hexvix/Cysview from Photocure ASA (Oslo, Norway) is a drug that preferentially accumulates in cancer cells in the bladder, making them glow bright pink during BLC. BLC with Hexvix/Cysview, as compared to standard white light cystoscopy alone, improves tumor detection and results in more complete resection, less residual tumors, and better management. A new study using real-world data from the BLC with Cysview Registry, the largest non-muscle-invasive bladder cancer registry in the U.S., has demonstrated that using BLC considerably reduced the risk of recurrence and prolonged time to recurrence in comparison to White Light alone. Furthermore, BLC in patients with primary tumors extended time to recurrence as compared to recurrent patients, indicating that BLC’s earlier use could result in more favorable long-term outcomes in a real-world setting.
In addition, a pilot study of bladder cancer patients at the Aarhus University Hospital (Aarhus, Denmark) showed that BLC with Hexaminolevulinate (HAL) during trans-urethral resection of bladder tumors (TURBT) could influence the immune cell composition and tumor microenvironment. According to the preliminary findings, BLC-guided TURBT alters the expression of immune cells of both the adaptive and innate immune system in comparison to WLC-guided TURBT. However, further studies will be needed to validate the clinical impact of these observations.
“These new study results continue to emphasize the importance of performing a thorough TURBT using Blue Light Cystoscopy in the treatment of bladder cancer, and also demonstrate the strong interest from the scientific community to investigate Hexvix/Cysview's potential immunologic effects in bladder cancer management,” said Dan Schneider, President and CEO of Photocure. “BLC has been shown to clinically increase TURBT quality, more accurately stage disease for treatment, and enable better recurrence monitoring, supporting the long-term utility to help improve the lives of patients with bladder cancer.”
Related Links:
Photocure ASA
Aarhus University Hospital
Latest Surgical Techniques News
- Handheld Device Improves Targeted Cell Collection for Early Ovarian Cancer Assessment
- FDA Approves First Sirolimus Drug-Eluting Balloon for Coronary In-Stent Restenosis
- Light-Activated Nanoparticles May Offer New Approach to Retinal Prostheses
- Handheld Infrared Imaging Device Supports Tumor Margin Assessment During Surgery
- Needle-Free Intrauterine Anesthesia Technique Reduces Pain During IUD Insertion
- Robotic Platform Advances Fetoscopic Treatment of Twin-to-Twin Transfusion Syndrome
- Patient-Specific AI Tool Aligns X-Rays With 3D Scans For Surgical Navigation
- FDA Clears Integrated Platform for Real-Time Cardiac Imaging and Catheter Guidance
- Hydrogel Dermal Supports Healing of Complex Wounds After Cancer Surgery
- New Microcatheter Enhances Lesion Crossing in Complex Coronary Interventions
- Integrated PET/MRI and EEG Improves Presurgical Lesion Localization in Pediatric Focal Epilepsy
- Integrated Perioperative Care Model Improves Recovery in Older Surgical Patients
- New Transvaginal Transducer Improves Imaging for Gynecology and Early Obstetrics
- FDA Approves Abbott Dual-Energy Catheter for Complex AFib Cases
- Mobile 3-in-1 Imaging System Advances Intraoperative Navigation
- First Thyroid Cancer-Specific Anxiety Scale Supports Patient-Centered Care
Channels
Artificial Intelligence
view channel
AI Improves Non-Contrast CT Interpretation for Time-Sensitive Stroke Assessment
Acute ischemic stroke occurs when a blood vessel in the brain becomes blocked, requiring rapid diagnosis to enable timely reperfusion therapy. Emergency departments often use computed tomography angiography... Read more
AI-Powered ECG Model Gains FDA Authorization for Emergency Cardiac Assessment
Powerful Medical’s PMcardio Queen of Hearts (ACS AI ECG Model) has received U.S. Food and Drug Administration (FDA) De Novo authorization, announced on September 15, 2026. The model is designed to identify... Read more
Critical Care
view channel
Anatomical Guidance System Improves Trauma Ultrasound Acquisition by Novice Users
Focused assessment with sonography for trauma (FAST) helps clinicians detect free fluid and signs of internal bleeding in injured patients, but obtaining reliable images can be difficult for inexperienced operators.... Read more
AI-Enhanced Handheld Ultrasound Improves Carotid Plaque Detection
Handheld ultrasound can miss small or faint carotid plaque, creating uncertainty in community screening. This gap makes it harder for frontline clinicians to decide who needs confirmatory imaging, closer... Read more
Noninvasive Imaging Approach Aims to Detect Basal Cell Carcinoma Before It Becomes Visible
Basal cell carcinoma is the most common form of skin cancer and can damage nearby structures such as the nose or eyes when it develops on the face. Diagnosis typically depends on visible skin changes,... Read more
Patient Care
view channel
EHR Model Flags High-Risk Periods in Patients with Metastatic Breast Cancer
Determining when patients with metastatic breast cancer are nearing the end of life remains difficult, often leading to intensive interventions with limited benefit. Prognostic uncertainty can delay goals-of-care... Read more
Virtual Reality Helps Claustrophobic Patients Complete Cardiac PET/CT Scans
Anxiety and claustrophobia—intense fear of confined spaces—often prevent patients from completing cardiac positron emission tomography/computed tomography (PET/CT). Aborted scans delay diagnosis, consume... Read more
Medical Imaging
view channel
New MRI Approach Captures Rapidly Decaying Tissue Signals
MRI measures signals generated as excited proton spins return toward equilibrium. However, some tissue signals decay so rapidly that conventional systems can miss them during the brief interval after excitation,... Read more
AI Tool Integrates MRI and Ultrasound to Detect Endometriosis
Endometriosis is a chronic condition in which tissue similar to the uterine lining grows outside the uterus, causing pain, heavy bleeding, and infertility. Diagnosis often depends on surgical visualization,... Read more
Health IT
view channel
New Tablet Platform Extends Stroke Neurorehabilitation Beyond the Clinic
Continuity and intensity of neurorehabilitation after stroke are critical for functional recovery, but access to ongoing therapy at home often remains limited. Hospitals and outpatient programs therefore... Read more
Smartphone App Improves Blood Pressure Control in Hypertension
Hypertension, or high blood pressure, is a major modifiable driver of cardiovascular, renal, and cerebrovascular morbidity. Despite effective therapies, many adults fail to achieve control, leading to... Read more
Point of Care
view channel
Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes
Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more
Microneedle Patch Enables At-Home Monitoring of Acute Kidney Injury
Kidney disease is often silent in its early stages, making timely detection difficult outside clinical settings. Early biomarkers such as neutrophil gelatinase–associated lipocalin can require blood draws... Read more
Business
view channel
Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery
As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Robotic Single-Port System Gains CE Mark for Transvaginal Gynecologic Procedures
Intuitive (Sunnyvale, CA, USA) announced that it has received CE mark approval for use of the da Vinci SP Single Port surgical system in transvaginal gynecologic procedures, marking the first such indication... Read more
